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MALDI imaging and profiling mass spectrometry of proteins typically leads to the detection
of a large number of peptides and small proteins but is much less successful for larger proteins:
most ion signals correspond to proteins of m/z  25,000. This is a severe limitation as many
proteins, including cytokines, growth factors, enzymes, and receptors have molecular weights
exceeding 25 kDa. The detector technology typically used for protein imaging, a microchannel
plate, is not well suited to the detection of high m/z ions and is prone to detector saturation
when analyzing complex mixtures. Here we report increased sensitivity for higher mass
proteins by using the CovalX high mass HM1 detector (Zurich, Switzerland), which has been
specifically designed for the detection of high mass ions and which is much less prone to
detector saturation. The results demonstrate that a range of different sample preparation
strategies enable higher mass proteins to be analyzed if the detector technology maintains high
detection efficiency throughout the mass range. The detector enables proteins up to 70 kDa to
be imaged, and proteins up to 110 kDa to be detected, directly from tissue, and indicates new
directions by which the mass range amenable to MALDI imaging MS and MALDI profiling MS
may be extended. (J Am Soc Mass Spectrom 2010, 21, 1922–1929) © 2010 American Society for
Mass Spectrometry
Since its inception 10 y ago, MALDI imagingmass spectrometry (imaging MS) has developedinto a powerful and versatile tool for biomedical
research [1, 2]. It is now routinely used for analyzing
peptides and small proteins up to 25 kDa [3–6], admin-
istered drugs and their metabolites [7], and recently
major improvements have been reported for lipids [8].
Despite this success, proteins exceeding 25 kDa are not
routinely detected. Proteins larger than 25 kDa include
many proteins with important biological activities, such
as most cytokines, growth factors, enzymes, receptors,
proproteins, and neuropeptide precursors. Increasing
the mass range of proteins amenable to MALDI imag-
ing MS might enable these biologically crucial proteins
to be included in current applications, e.g., biomarker
discovery.
The most common technique currently used to ac-
cess larger proteins in MALDI imaging MS analyses is
based on proteolytic digestion of the tissue’s proteins
followed by MALDI imaging MS of their tryptic pep-
tides. Note on-tissue digestion has the additional ad-
vantage that it can be applied to formalin fixed tissues
as proteolytic peptides can be generated that are not
bound within the cross-linked protein matrix. For ex-
ample, Djidja et al. used on-tissue digestion to deter-
mine that the 78 kDa protein GRP78 may be a new
candidate protein biomarker of pancreatic adenocarci-
noma [9]. In principal, this ‘bottom-up’ strategy could
enable proteins of any mass to be detected. In practice
the large increase in complexity associated with proteo-
lysing the entire tissue’s protein content will cause
many tryptic peptides to have identical nominal mass
[1], thus undermining the identification of potential
biomarkers. Furthermore, bottom-up MALDI imaging
MS discards all information regarding protein isoforms
unless the appropriate tryptic peptides are explicitly
included in the analysis. Recently it was shown that
post-mortem protein degradation of GRP78, the protein
identified as a candidate biomarker in the above bottom-
up strategy, is isoform-dependent [10], and it is difficult
to control protein degradation in human tissue sam-
ples. Direct MALDI imaging MS of proteins, if per-
formed with sufficient mass resolution, would have the
advantage that many isoforms can be identified on the
basis of the resulting difference in mass.
MALDI imaging MS of higher mass proteins has
been conspicuous by its rarity. Three recent articles
have reported sample preparation methods that help
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increase the mass range of proteins amenable to the
technique. The first method uses extensive water wash-
ing steps to deplete abundant soluble proteins, followed
by application of a matrix solution containing a high
percentage of organic solvent. This preparation allowed
the detection of a 28 kDa integral crystalline lens
membrane protein [11], but would be difficult to apply
as a general strategy as its success is based solely on
extensive on-tissue protein purification of membrane
proteins (which remain anchored to the insoluble mem-
brane during the repeated water washes). The second
method uses Triton X-100 and xylene to aid the detec-
tion of proteins ranging from m/z 25,000 to 50,000 [12].
The images were very noisy, indicating insufficient
intensity, but provided several lines of reasoning for the
lack of sensitivity for higher mass proteins. The use of
organic solvents or Triton X-100 suggests higher mass
proteins may not be detected because they are not
efficiently solubilized by the matrix solution and con-
sequently are not extracted from the tissue. Franck et al.
recently extended these sample preparation strategies
and reported how the solvents 1,1,1,3,3,3-hexafluoro-2-
propanol (HFIP) and 2,2,2-trifluoroethanol (TFE) could
also be used for MALDI MS analysis of tissues [13].
Unfortunately the very low viscosity and harsh chemi-
cal abrasiveness of HFIP and TFE make them difficult to
apply with the automated sample preparation stations
commonly used for MALDI imaging MS.
All of the above sample preparation strategies report
empirical methods by which the signals of higher mass
proteins could be increased but have not addressed an
inherent weakness in the mass spectrometry: MALDI
predominantly generates singly charged protein ions so
a high mass protein ion will be detected at high m/z. The
technology typically used for protein MALDI imaging
or profiling MS, a time-of-flight (TOF) mass spectrom-
eter equipped with a micro-channel plate (MCP) detec-
tor, is not well suited to the detection of high m/z ions
[14]. The initial impact of an ion onto the detector
releases some electrons, which are then amplified
through the MCP to generate the signal. The MCP
detection process is known to favor lower m/z ions
because the ion to electron conversion efficiency is
nonlinearly dependent on velocity, exhibiting a ‘thresh-
old’ velocity below which no signal is obtained, then
increasing rapidly with increasing velocity before
reaching a plateau in which detector response in insen-
sitive to increasing velocity [15]. In TOF analyzers ion
velocity is inversely proportional to the square root of
the m/z ratio. Ions of high m/z may not be detected
within the optimum detection-efficiency plateau and thus
generate less detector signal. Furthermore, MCP detectors
have a finite amplification potential within any single
time-of-flight scan [16, 17]. Lowermass ions, detected first,
can saturate the detector, leading to even lower detection
efficiencies for higher mass ions [16, 17].
The lower sensitivity of TOF mass analyzers using
MCP detectors for higher mass ions has been known for
some time. Chen et al. have demonstrated that the
lower ion-to-electron conversion of higher mass ions,
detector saturation, and m/z-dependent ion transmis-
sion (to the detector) are sufficient to explain the
entirety of the observed decrease in signal intensity
with increasing mass (without invoking any chemical
bias) [14]. This study was primarily concerned with
oligonucleotide detection but also demonstrated that
protein analysis provided equivalent results. Further-
more, this investigation of the instrumental effects that
are responsible for the decreased sensitivity of higher
mass ions was performed using a simple mixture of just
seven oligonucleotides. Even with this relatively simply
system, saturation of the MCP detector could reduce the
intensities of the heavier oligonucleotides by80% [17].
In MALDI applications in proteomics, such as peptide
fingerprinting and LC-MALDI, high mass insensitivity
is rarely a problem since complex mixtures of proteins
with masses above 20,000 are rarely analyzed. The
tissue sections analyzed by MALDI imaging and pro-
filing MS can result in a significant background, which
is more intense in the low mass region but continues
throughout the entire mass range [18, 19]. When detect-
ing a wide mass range, this background will exacerbate
MCP detector saturation and further decrease the de-
tection efficiency for higher mass protein ions. Low
mass ions are routinely deflected (or the detector bias
switched) to avoid intense low mass ions, such as
matrix and lipid ions, from saturating the detector [17].
Nevertheless in MALDI imaging and profiling MS the
significant background and lower mass peptide and
protein ions represent a high ion load that will reduce
detection efficiency for higher mass ions.
Hillenkamp and workers have investigated high-
mass detection of MALDI generated ions using a single
stage dynode [20] and used this technology to analyze
large molecular ions [21, 22]. Commercial detectors
explicitly designed for the detection of higher mass
proteins and protein complexes have been designed by
Comet and CovalX. The Comet Macromizer is based on
a superconducting tunnel junction (STJ) cryodetector.
The STJ detector can detect very low kinetic energies
and is able to perform single ion detection on the basis
of their kinetic energy [23]. In a MALDI-TOF instru-
ment, the kinetic energy of an ion is determined by the
accelerating potential and charge state of the ion, con-
sequently an STJ detector is able to detect all ions with
equal efficiency (no mass dependence) [20]. A particular
advantage of STJ detectors is that multiply charged ions
can be distinguished on the basis of their higher kinetic
energy. The higher detection efficiency and higher
capacity of the STJ detector has been exploited for the
analysis of complex protein mixtures: it was demon-
strated that the STJ detector could detect multiple
higher mass proteins that were not detected using an
MCP [24]. Unfortunately the Comet Macromizer is no
longer commercially available.
The high mass detectors from CovalX, HM1 and
HM2, use an ion conversion detector to increase the
detection sensitivity of higher mass ions: incident ions
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first collide with a conversion dynode array to create
smaller secondary ions, which are then reaccelerated
into a secondary electron multiplier as higher velocity
ions that are detected with higher sensitivity [25]. In
addition to more sensitive detection of higher mass
protein ions, these high mass detectors possess a much
larger charge capacity and thus are not as prone to
detector saturation as the typical MCP detector [25].
Here we demonstrate that a commercial detection sys-
tem optimized for high mass ions and which is much
less prone to detector saturation, CovalX’s HM1 detec-
tor, significantly improves the sensitivity of MALDI
imaging and profiling MS for higher mass proteins. Its
combination with recently reported sample prepara-
tion procedures for accessing higher mass proteins
enables these very large ions to be detected from
tissue with higher sensitivity, and includes the dem-
onstration of MALDI imaging MS of proteins exceed-
ing 50 kDa and the first MALDI profiling MS of
proteins exceeding 100 kDa.
Experimental
Materials
Sinapinic acid (SA), 1,1,1,3,3,3-hexafluoro-2-propanol
(HFIP), trifluoroacetic acid (TFA), ethanol (EtOH), ace-
tone, acetonitrile (AcN), chloroform, Tween 20, sodium
dodecyl sulfate (SDS), Triton X-100, and hydrogen
peroxide were purchased from Sigma-Aldrich (Zwijn-
drecht, The Netherlands) and used without further
purification. Peroxidase-blocking reagent containing
3% hydrogen peroxide was purchased from Dako (Hev-
erlee, Belgium).
Samples
Adult male Wistar rats weighing 250–350 g and adult
male wild type mice weighing 30–50 g (animal use
accreditation by the French ministry of the agriculture
no. 04,860) maintained under standard care were used.
Animals were sacrificed by decapitation and immedi-
ately dissected to remove the brain, which was then
flash frozen in liquid nitrogen and stored at 80°C.
Tissue Preparation
Thin 12 m thick tissue sections were cut using a
cryomicrotome and thaw mounted onto conductive
glass slides (Delta Technologies, Stillwater, MN, USA).
The tissue sections were then freeze dried for 1 h
followed by different washing steps to remove salts and
abundant lipids. Each tissue section was first immersed
in a bath of cold acetone for 30 s followed by a bath of
cold EtOH 95% for 30 s, and finally immersed in
chloroform for 1 min. Different sample preparation
procedures for MALDI imaging and profiling MS of
higher mass proteins were then compared by manually
depositing arrays of 0.5 L droplets of matrix solution
using a micropipette (profiling) or applying a uniform
coating of the matrix solution using an ImagePrep auto-
mated sprayer (Bruker Daltonics, Bremen, Germany).
Standard
Mouse brain tissue sections were washed with chloro-
form and ethanol and prepared with a matrix solution
of 20 mg/mL SA in AcN:0.1% TFA (7:3, vol/vol).
HFIP
A matrix solution of 20 mg/mL SA in pure HFIP was
deposited onto the washed tissue, followed by the
addition of a recrystallization solution of 20 mg/mL SA
in AcN: 0.1% TFA (7:3, vol/vol) [13].
Leinweber
Mouse brain tissue sections were placed onto a droplet
of 20 mg/mL SA in 90% EtOH containing 0.5% Triton
X-100 and 0.1% TFA. After the matrix solution was dry,
a droplet of a suspension of SA in xylene (freshly
prepared by sonication) was deposited onto the tissue
and the tissue dried in a vacuum desiccator. Additional
droplets of matrix were then added using 20 mg/mL
SA solutions in 90% EtOH and in 50% AcN [12].
Tween
A matrix solution of 20 mg/mL SA in AcN:0.1% TFA
(7:3, vol/vol) and containing a low concentration of
Tween 20 was deposited onto the washed tissue and
allowed to dry [26].
H2O2
A 3% solution of H2O2 was deposited onto the tissue
and left to incubate for 30 min in a saturated vapor
pressure chamber. The tissue was then dried in a
vacuum desiccator and prepared using a matrix solu-
tion of 20 mg/ml SA in AcN:0.1% TFA (7:3, vol/vol).
Mass Spectrometry
All experiments were performed using an AutoFlex III
MALDI-TOF (Bruker Daltonics, Bremen, Germany)
equipped with an MCP detector and a high mass
detector (HM1, CovalX, Switzerland) and were con-
trolled using FlexControl 3.0. All protein spectra were
then processed with FlexAnalysis 3.0 using the Top Hat
baseline subtraction method and four cycles of Gauss
smoothing with a width of 2 m/z.
MALDI mass analysis of higher mass proteins was
found to require higher laser fluence. For these experi-
ments, the laser offset was set to 30%, laser range to
20%, laser power to 70%, and the laser focus to medium.
Mass analysis was performed using delayed extraction
(800 ns), 20 kV acceleration voltage, and all ions below
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3.5 kDa were suppressed using an ion deflector. The ion
signals from 3.5–100 k m/z were recorded using a 0.5
GHz digitization rate and the mass spectra externally
calibrated using insulin clusters and BSA clusters ([nM 
H], n  1–4 for insulin and n  1–2 for BSA).
MALDI imaging MS experiments were performed
using a pixel (and laser raster) size of 200  200 m,
1000 laser shots for each pixel, and were acquired in
fully automated mode using FlexImaging 2.1. Mass
analysis of each pixel took 6 s.
Results and Discussion
It has previously been shown that washing the tissue
sections with organic solvents such as chloroform and
EtOH before matrix deposition increases the number
and intensities of protein signals up to 20 kDa [27–29].
To test if the increased high mass sensitivity and charge
capacity of the high mass HM1 detector may benefit
imaging MS of higher mass proteins, mouse brain tissue
sections were washed with chloroform and ethanol,
prepared with a matrix solution of 20 mg/mL SA in
AcN:0.1% TFA (7:3, vol/vol), and then analyzed using
an AutoFlex III MALDI-ToF equipped with an MCP
and a HM1 detector. When selected, the HM1 detector
is mechanically moved into the ion optical flight path,
in front of the MCP detector (18 cm on the Autoflex III).
Once the detector is in position, the post-acceleration
voltage (20 kV) and gain voltage (2 kV) are applied and
the detector signal switched to the output of the HM1
detector. The whole process takes 1 min.
Figure 1 shows the spectra obtained by accumulating
of 10,000 laser shots over the whole tissue. The MS
spectrum recorded with the MCP detector shows many
signals up to m/z 20,000 but only a few very low
intensity peaks of higher m/z (Figure 1a). In contrast, the
mass spectrum obtained with the high mass HM1
detector contains many peaks up to m/z 50,000 (Figure
1b). Several studies have established that the detection
sensitivity of higher mass proteins using an MCP de-
tector is highly attenuated in multi-component mix-
tures, due to detector saturation [14, 17, 24, 25]. The
tissues analyzed in a MALDI imaging and profiling MS
analysis contain a very large number of proteins that
will exacerbate this loss of sensitivity due to detector
saturation.
Images of proteins were obtained from another tis-
sue section, obtained from a different region of a mouse
brain, after washing in organic solvents and SA matrix
deposition by automatic spraying using both the MCP
and the high mass HM1 detectors. The dataset recorded
with the high mass HM1 detector included many pro-
tein signals above m/z 30,000 with a mean S/N level
above 4, Figure 2. Molecular images of the higher mass
protein peaks detected at m/z 44,600, 46,800, and 66,000
all generated smooth images with clearly different
distributions.
The highest mass MALDI images previously re-
ported show the distributions of a protein detected at
m/z 47,900 [12] and at m/z 66,460 [30]. The former
publication includes many peaks between 25 and 50
kDa, whereas the latter reports only the protein at
66,460. In the former report the tissue was prepared
using a stepwise sample preparation protocol using
Triton X-100 and xylene, which had been developed for
the analysis of higher mass proteins, but the experiment
was performed using an MCP detector. The results
shown above clearly indicate that an MCP detector may
under-represent protein ions of higher m/z.
Several sample preparation strategies have been re-
ported for the analysis of higher mass proteins. A
comparison of the mass spectra recorded with an MCP
detector and the high mass HM1 detector for several of
these sample preparation strategies explicitly demon-
strates the higher sensitivities that can be obtained
using the high mass HM1 detector. Figures 3a and b
show the mass spectra obtained using the Triton X-100
and xylene protocol developed by Leinweber et al. [12].
The mass spectrum obtained using the MCP contains
weak peaks at higher m/z with low S/N, which are
consistent with the mass spectra and pixilated images
Figure 1. Example MS spectra from a single mouse brain tissue
section after deposition of the matrix solution 20 mg/mL SA in
AcN:0.1% TFA (7:3, vol/vol) and measured using an MCP detec-
tor (a) and the high mass HM1 detector (b). The number of peaks
above 20 kDa with S/N 	 4 is indicated. The error bars show the
variability of the higher mass protein peaks across six repeats.
Note that the two detectors have different intensity scales.
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included in the original article. When analyzed using
the high mass HM1 detector intense peaks up to 50,000
m/z and several weaker peaks at even higher mass are
obtained. Franck et al. recently reported a multistep
sample preparation protocol based on the highly corro-
sive solvent HFIP [13]. The mass spectra obtained with
the MCP can contain weak peaks up to 50,000 m/z,
Figure 3c tissue 2, but sometimes the peaks are barely
discernable, Figure 3c tissue 1. When analyzed with the
high mass HM1 detector, both tissues generated a series
of high intensity peaks up to 60,000 m/z. On occasion,
the combination of the HFIP sample treatment and a
high mass HM1 detector even led to the detection of
peaks exceeding 100,000 m/z (supplementary Figure 1,
which can be found in the electronic version of this
article).
Figures 1, 2, and 3 demonstrate the increased sensi-
tivity provided by the high mass HM1 detector and also
indicate that low detection efficiency of higher mass
proteins is one of the principal causes for their absence
in previous MALDI imaging MS studies. Further sup-
port for this assertion was obtained by testing newly
reported sample preparation strategies: Mainini et al.
recently demonstrated that the addition of a small
amount of chaotropic agents or detergents (0.05% SDS,
PPS, or Triton X-100) to the matrix solution improved
the intensity and number of protein peaks in the mass
spectrum [26]. These experiments were performed us-
ing an MCP detector, and the majority of the protein
peaks were detected at less than 25,000 m/z. The in-
creased sensitivity for high mass proteins provided by
the HM1 detector revealed that chaotropes and deter-
gents could also aid in the detection of higher mass
proteins. Figure 4a shows how the intensity of the peaks
between 40,000 and 50,000 m/z increases with increasing
Tween content. An imaging analysis of two adjacent
tissue sections, only one of which was prepared with
Tween, clearly demonstrates that the higher mass pro-
teins were only obtained from the tissue prepared with
Tween (Figure 4a).
We then tested whether any of the steps from immu-
nohistochemical protocols could be adapted for MALDI
imaging and profiling MS, to improve the extraction
and thus detection of higher mass proteins. Remark-
ably, it was found that the use of a commercially
available peroxidase blocking solution containing 3%
H2O2 also enhanced the detection of higher mass pro-
teins. Figure 4b shows examples of profiles obtained
from adjacent tissue sections prepared by first treating
the tissue with a 3% H2O2 solution and then depositing
the standard 20 mg/mL sinapinic acid matrix solution.
As can be seen, a series of intense protein peaks were
obtained up to 50 kDa, as well as some weaker peaks of
even higher mass. The application of H2O2 has been
shown to oxidize cysteine and methionine residues [31]
and to lead to the partial denaturation of proteins [32].
As occurs with chaotropes such as SDS, we speculate
that H2O2 aided denaturation of proteins might increase
their solubilization in the matrix solution.
Closer inspection of the spectra obtained with the
MCP and HM1 detectors, Figures 1 and 3, revealed that
several of the higher mass peaks observed with the
HM1 detector were sometimes also observed with the
MCP but were detected with much lower intensity. This
is consistent with the higher detection efficiency of
higher mass ions using the HM1 detector: the profiling
mass spectra are the result of 10 k accumulated single-
laser-shot mass spectra, the HM1 detector ensures a
larger fraction of the higher mass ions contribute to the
final accumulated spectrum. Nevertheless, the underly-
Figure 2. Mean mass spectrum and molecular images of proteins detected at m/z 44,600, 46,800, and
66,000 from a mouse brain tissue section using the high mass HM1 detector. The tissue was washed
with chloroform and ethanol before deposition of the matrix solution 20 mg/mL SA in AcN:0.1% TFA
(7:3, vol/vol).
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ing spectrum, the ions produced by the experiment,
remains identical. For MALDI imaging MS experiments,
in which each pixel is analyzed with fewer laser shots, the
increased sensitivity offered by the high mass HM1 detec-
tor for higher mass proteins ensures that more pixels
contribute signal to the final image (Figure 2).
The above results demonstrate that a range of differ-
ent sample preparation strategies enable higher mass
proteins to be analyzed provided they are detected with
sufficient efficiency. However, the mass resolution of
the peaks in the spectra measured with the high mass
HM1 detector are lower than those measured using
the MCP detector, and is a consequence of the post-
acceleration of the secondary ions after the conversion
dynode (which provides the high mass sensitivity). The
low mass resolution of the high mass HM1 detector
reduces its suitability for MALDI imaging and profiling
MS because too many protein signals overlap. Never-
theless, it clearly demonstrates that the lack of detection
of higher mass protein ions is partly due to the low
detection efficiency of higher mass protein ions using
MCPs, a phenomenon which is exacerbated by the
significant chemical background. The HM1 detector has
been designed for the detection of very large protein
ions and protein complexes, including masses exceed-
ing 106 Da. For very large molecules, i.e., several
hundred kDa and greater, the detected peak width is
limited by the isotopic distribution and adduct forma-
tion [33] and not by the response time of the detector.
For the mass range accessible by MALDI imaging and
Figure 3. Comparison of spectra obtained from previously published sample preparation protocols
for higher mass proteins using an MCP and a high mass HM1 detector. Leinweber [12] protocol using
an MCP (a) and the HM1 detector (b). HFIP protocol [13] using an MCP (c) and the HM1 detector (d).
The number of peaks above 20 kDa with a S/N 	 4 is indicated. The error bars show the variability
of the higher mass protein peaks across six measurement repeats. Note that the two detectors have
different intensity scales.
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profiling MS, below 150 kDa, it would be beneficial to
decrease the response time of the high mass HM1
detector (350 ns), or CovalX’s revised HM2 detector
(250 ns), to 10 ns while maintaining improved sensi-
tivity and lack of saturation.
Conclusion
Tissue analysis using MALDI imaging and profiling MS
experiments can generate rich spectra containing many
peptides and proteins. However, the number of lower
mass proteins, 25 kDa, far exceeds those of higher
mass. The results shown here clearly demonstrate that
many existing sample preparation protocols generate
higher mass protein ions but the ions are detected with
low efficiency using the standard MCP detector. The
increased signal intensities of higher mass proteins
obtained with the high mass HM1 detector, relative to
an MCP, are consistent with the latter’s known loss of
detection sensitivity with increasing mass and ion load
[14]. MALDI imaging and profiling MS generates a
significant chemical background [18], which will exac-
erbate any losses of sensitivity due to saturation. The
increased detection sensitivity and, particularly, the
lack of detector saturation provided by the HM1 detec-
tor, enables the acquisition of spectra containing pro-
teins up to 70 kDa as well as the detection of even
higher mass proteins. These results, the first reporting
the utility of such detectors for MALDI imaging and
profiling MS, demonstrate that the sensitive analysis of
higher mass proteins directly from tissue requires a
detector technology that can withstand the high chem-
ical background and detect higher mass proteins with
higher efficiency.
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